These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35760718)

  • 21. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
    Francis PT
    J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.
    Feleke R; Reynolds RH; Smith AM; Tilley B; Taliun SAG; Hardy J; Matthews PM; Gentleman S; Owen DR; Johnson MR; Srivastava PK; Ryten M
    Acta Neuropathol; 2021 Sep; 142(3):449-474. PubMed ID: 34309761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia.
    Jellinger KA
    Front Neurol Neurosci; 2009; 24():114-125. PubMed ID: 19182469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms: A protocol for systematic review and meta-analysis.
    Wang H; Wang W; Shi H; Han L; Pan P
    Medicine (Baltimore); 2020 Oct; 99(40):e21871. PubMed ID: 33019386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences.
    Peraza LR; Colloby SJ; Firbank MJ; Greasy GS; McKeith IG; Kaiser M; O'Brien J; Taylor JP
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1135-46. PubMed ID: 26270627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromogranin A Analysis in the Differential Diagnosis Across Lewy Body Disorders.
    Gmitterova K; Varges D; Schmitz M; Zafar S; Maass F; Lingor P; Zerr I
    J Alzheimers Dis; 2020; 73(4):1355-1361. PubMed ID: 31929170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia.
    Tilley BS; Patel SR; Goldfinger MH; Pearce RKB; Gentleman SM
    J Parkinsons Dis; 2021; 11(4):1641-1650. PubMed ID: 34334423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topography of cortical thinning in the Lewy body diseases.
    Ye R; Touroutoglou A; Brickhouse M; Katz S; Growdon JH; Johnson KA; Dickerson BC; Gomperts SN
    Neuroimage Clin; 2020; 26():102196. PubMed ID: 32059167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
    Kalaitzakis ME; Pearce RK; Gentleman SM
    Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [
    Andersen KB; Hansen AK; Damholdt MF; Horsager J; Skjaerbaek C; Gottrup H; Klit H; Schacht AC; Danielsen EH; Brooks DJ; Borghammer P
    Mov Disord; 2021 Sep; 36(9):2057-2065. PubMed ID: 33899255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.
    Vranová HP; Hényková E; Kaiserová M; Menšíková K; Vaštík M; Mareš J; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
    J Neurol Sci; 2014 Aug; 343(1-2):120-4. PubMed ID: 24928081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of pharmacological interventions for people with Lewy body dementia.
    Watts KE; Storr NJ; Barr PG; Rajkumar AP
    Aging Ment Health; 2023 Feb; 27(2):203-216. PubMed ID: 35109724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.